Dr. Agarwal's Eye Hospital Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Dr. Agarwal's Eye Hospital Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ₹7 per ₹100 of sales comes from others' credit, against ₹6 from others' credit three years earlier. Less money tied up than 97% of Healthcare companies in India.
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹192 of operating cash. Higher than 86% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹192Over the last 3 years, every ₹100 of reported profit came with ₹192 of operating cash.
Higher than 86% of Healthcare companies in India.
Self-Funding Ratio
1.2×Over the last 3 years its own operating cash covered its investment spending (capex) 1.2 times.
Lower than 58% of Healthcare companies in India.
Cash Locked Ratio
−₹7Money owed to suppliers is larger than money owed by customers plus stock: ₹7 per ₹100 of sales comes from others' credit, against ₹6 from others' credit three years earlier.
Less money tied up than 97% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹16Sales grew 76% in 3 years; of every extra ₹100 of sales, ₹16 became extra profit.
Higher than 50% of Healthcare companies in India.
Asset Productivity Ratio
+76% / +97%In 3 years sales changed by +76% while total assets changed by +97%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
9.9×Debt due within a year is covered 9.9 times by its yearly operating cash.
Higher than 76% of Healthcare companies in India.
Cash Cushion Ratio
−10%Debt, after subtracting cash, equals 10% of its market value (net debt).
Lower than 77% of Healthcare companies in India.
Tangible Assets Ratio
96%Of every ₹100 the company owns, ₹96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 55% of Healthcare companies in India.
Tangible Net Worth Ratio
92%Of every ₹100 of net worth, ₹92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 59% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Dr. Agarwal's Eye Hospital Limited owes ₹0.55 for every ₹1 it owns. Net profit rose 28% in the year to Mar 2026, and grew 24% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
31.8Investors pay ₹31.8 for every ₹1 of Dr. Agarwal's Eye Hospital Limited's yearly profit, lower than 60% of Healthcare companies in India.
P/B ratio
7.06The share price is 7.06 times Dr. Agarwal's Eye Hospital Limited's book value per share, higher than 72% of Healthcare companies in India.
Market cap
₹2,443 CrThe total market value of all of Dr. Agarwal's Eye Hospital Limited's shares at today's price (share price × number of shares), smaller than 60% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹346 CrWhat Dr. Agarwal's Eye Hospital Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹716.56Net worth divided by the number of shares. The share price of ₹5,056 is 7.1 times this, which is the P/B above.
Return on equity (ROE)
22.2%Dr. Agarwal's Eye Hospital Limited earned 22.2% on its shareholders' money over the last year, higher than 85% of Healthcare companies in India.
Owes vs Owns
0.55×Dr. Agarwal's Eye Hospital Limited owes ₹0.55 for every ₹1 it owns (moderate), higher than 89% of Healthcare companies in India.
Dividend yield
0.16%Dr. Agarwal's Eye Hospital Limited pays 0.16% of its share price as dividends a year, lower than 75% of dividend-paying Healthcare companies in India.
Revenue growth
+19%Revenue rose 19% in the year to Mar 2026, and grew 21% a year on average over 3 years.
Profit growth
+28%Net profit rose 28% in the year to Mar 2026, and grew 24% a year on average over 3 years.
Profit margin
14.9%Dr. Agarwal's Eye Hospital Limited keeps ₹15 of every ₹100 of revenue as net profit.
Cash quality
2.1×Cash from Dr. Agarwal's Eye Hospital Limited's business was 2.1× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
8.6×Dr. Agarwal's Eye Hospital Limited's operating profit covered its interest costs 8.6 times in the year to Mar 2026.
Cash vs debt
Net debtDr. Agarwal's Eye Hospital Limited had ₹230 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Dr. Agarwal's Eye Hospital Limited's P/E ratio?
Investors pay ₹31.8 for every ₹1 of Dr. Agarwal's Eye Hospital Limited's yearly profit, lower than 60% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Dr. Agarwal's Eye Hospital Limited: ₹2,443 Cr ÷ ₹346 Cr (31 Mar 2026) = 7.1.
What is Dr. Agarwal's Eye Hospital Limited's return on equity?
Dr. Agarwal's Eye Hospital Limited earned 22.2% on its shareholders' money over the last year, higher than 85% of Healthcare companies in India.
How much does Dr. Agarwal's Eye Hospital Limited owe compared with what it owns?
Dr. Agarwal's Eye Hospital Limited owes ₹0.55 for every ₹1 it owns (moderate), higher than 89% of Healthcare companies in India.
Does Dr. Agarwal's Eye Hospital Limited pay a dividend?
Yes. Dr. Agarwal's Eye Hospital Limited pays 0.16% of its share price as dividends a year, lower than 75% of dividend-paying Healthcare companies in India.
Is Dr. Agarwal's Eye Hospital Limited's revenue growing?
Revenue rose 19% in the year to Mar 2026, and grew 21% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.